Rosetta Genomics Ltd. Induced Conversion of Convertible Debt Expense
Rosetta Genomics Ltd. reported Induced Conversion of Convertible Debt Expense of $1.55 million for the 12-month period ending 2012-12-31, per its 20-F filed 2015-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InducedConversionOfConvertibleDebtExpense · last filed 2015-03-16
| Period end | Induced Conversion of Convertible Debt Expense 6 month | Induced Conversion of Convertible Debt Expense 12 month | Induced Conversion of Convertible Debt Expense 12 month as first filed |
|---|---|---|---|
| 2012-12-31 | $1.55M 20-F · filed 2015-03-16 | $1.57M 20-F · filed 2013-03-22 | |
| 2012-06-30 | $2.06M 6-K · filed 2012-09-28 |